Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2015 1
2018 1
2019 2
2020 2
2021 5
2022 5
2023 2
2024 4
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Methotrexate in inflammatory bowel disease.
Feagan BG, Alfadhli A. Feagan BG, et al. Among authors: alfadhli a. Gastroenterol Clin North Am. 2004 Jun;33(2):407-20, xi. doi: 10.1016/j.gtc.2004.03.001. Gastroenterol Clin North Am. 2004. PMID: 15177546 Review.
Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases.
AlEnizi A, AlSaeid K, Alawadhi A, Hasan E, Husain EH, AlFadhli A, Ghanem A, Abutiban F, Ali Y, Al-Herz A, Mohammed K, Alkandari W, Aldei A, Alhajeri H, Dehrab A, Hayat S. AlEnizi A, et al. Among authors: alfadhli a. Int J Rheumatol. 2018 May 13;2018:5217461. doi: 10.1155/2018/5217461. eCollection 2018. Int J Rheumatol. 2018. PMID: 29861734 Free PMC article. Review.
Accelerating the elimination of hepatitis C in Kuwait: An expert opinion.
Hasan F, Alfadhli A, Al-Gharabally A, Alkhaldi M, Colombo M, Lazarus JV. Hasan F, et al. Among authors: alfadhli a. World J Gastroenterol. 2020 Aug 14;26(30):4415-4427. doi: 10.3748/wjg.v26.i30.4415. World J Gastroenterol. 2020. PMID: 32874054 Free PMC article. Review.
Impact of tumor necrosis factor antagonist combination and anti-integrin therapies on body mass index in inflammatory bowel disease: A cross-sectional study.
Shehab M, Alali A, Al-Hindawi A, Alsayegh A, Aldallal U, Abdullah I, Albaghli A, Alrashed F, Alfadhli A, Bessissow T. Shehab M, et al. Among authors: alfadhli a. Front Med (Lausanne). 2023 Jan 6;9:1045661. doi: 10.3389/fmed.2022.1045661. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36687448 Free PMC article.
Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study.
Shehab M, Alrashed F, Alfadhli A, Alsayegh A, Aldallal U, Alsayegh M, Cherian P, Alkhair I, Thanaraj TA, Channanath A, Dashti AA, Albanaw A, Ali H, Abu-Farha M, Abubaker J, Al-Mulla F. Shehab M, et al. Among authors: alfadhli a. Front Med (Lausanne). 2022 Jul 4;9:933996. doi: 10.3389/fmed.2022.933996. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35860742 Free PMC article.
24 results